Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America mHealth Market, by Type
1.4.2 North America mHealth Market, by Services
1.4.3 North America mHealth Market, by Devices
1.4.4 North America mHealth Market, by Stakeholders
1.4.5 North America mHealth Market, by Application
1.4.6 North America mHealth Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2015, Jun – 2020,Feb) Leading Players
Chapter 4. North America mHealth Market by Type
4.1 North America Services Market by Country
4.1.1 North America mHealth Services Market by Type
4.1.1.1 North America Monitoring services Market by Country
4.1.1.2 North America Diagnosis services Market by Country
4.1.1.3 North America Healthcare Systems Strengthening Services Market by Country
4.1.1.4 North America Other Services Market by Country
4.2 North America Devices Market by Country
4.2.1 North America mHealth Devices Market by Type
4.2.1.1 North America BP Monitors Market by Country
4.2.1.2 North America Cardiac Monitors Market by Country
4.2.1.3 North America Pulse Oximetry Market by Country
4.2.1.4 North America Blood Glucose Meters Market by Country
4.2.1.5 North America Apnea & Sleep Monitors Market by Country
4.2.1.6 North America Neurological Monitors Market by Country
4.2.1.7 North America Wearable Fitness Sensor Device & Heart Rate Meters Market by Country
4.2.1.8 North America Others Market by Country
Chapter 5. North America mHealth Market by Stakeholders
5.1 North America Mobile Operators Market by Country
5.2 North America Device Vendors Market by Country
5.3 North America Healthcare Providers Market by Country
5.4 North America Content Players Market by Country
Chapter 6. North America mHealth Market by Applications
6.1 North America Cardiovascular Diseases Market by Country
6.2 North America Diabetes Market by Country
6.3 North America Respiratory Market by Country
6.4 North America Neurology Market by Country
6.5 North America Other Applications Market by Country
Chapter 7. North America mHealth Market by Country
7.1 US mHealth Market
7.1.1 US mHealth Market by Type
7.1.1.1 US mHealth Services Market by Type
7.1.1.2 US mHealth Devices Market by Type
7.1.2 US mHealth Market by Stakeholders
7.1.3 US mHealth Market by Applications
7.2 Canada mHealth Market
7.2.1 Canada mHealth Market by Type
7.2.1.1 Canada mHealth Services Market by Type
7.2.1.2 Canada mHealth Devices Market by Type
7.2.2 Canada mHealth Market by Stakeholders
7.2.3 Canada mHealth Market by Applications
7.3 Mexico mHealth Market
7.3.1 Mexico mHealth Market by Type
7.3.1.1 Mexico mHealth Services Market by Type
7.3.1.2 Mexico mHealth Devices Market by Type
7.3.2 Mexico mHealth Market by Stakeholders
7.3.3 Mexico mHealth Market by Applications
7.4 Rest of North America mHealth Market
7.4.1 Rest of North America mHealth Market by Type
7.4.1.1 Rest of North America mHealth Services Market by Type
7.4.1.2 Rest of North America mHealth Devices Market by Type
7.4.2 Rest of North America mHealth Market by Stakeholders
7.4.3 Rest of North America mHealth Market by Applications
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Johnson and Johnson
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental &Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 DexCom, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Samsung Electronics Co., Ltd. (Samsung Group)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Omron Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 AllScripts Healthcare Solutions, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.1 Cerner Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
